Saturday, August 10, 2013

Sarah Jessica Parker, Gwyneth Paltrow and Kate Hudson at the Tiffany & Co. Blue Book Ball in New York

Sorry, I could not read the content fromt this page.

View the original article here

Fish and sauerkraut

Does anyone know if fish and sauerkraut match together.. chemically?? Because I ate them together this morning and vormited all out, I don't even know why. It may be because of somekind of reaction between them but I really don't know. 

Help?


View the original article here

Clinical Trials Helped One Woman's Fight Against Cancer

News Picture: Clinical Trials Helped One Woman's Fight Against CancerBy Barbara Bronson Gray
HealthDay Reporter

THURSDAY, April 18 (HealthDay News) -- Monica Barlow, a 35-year-old from Maryland, was training for a half-marathon when she noticed she couldn't shake a bad cough and ongoing fatigue. After a couple of rounds of antibiotics from an urgent care clinic didn't work, she sought another opinion.

A CT scan brought wrenching news: There was a tumor in her left lung.

"I never smoked, I eat well, exercise and had never had any medical problems prior to this," Barlow said. "To say it was a shock doesn't even begin to describe it."

Four years later, Barlow has been through a series of ups and downs. After learning the cancer had spread to her lymph nodes and liver, she started chemotherapy, which only shrunk the tumors temporarily. She then joined two consecutive clinical trials, each offering to help control her cancer with novel drugs.

Barlow, who is director of public relations for the Baltimore Orioles baseball team, credits her participation in those clinical trials with prolonging her life.

Clinical trials test potentially promising treatments for a wide range of challenging diseases. But it can be difficult to find a good match for your particular situation and tough to know where to start looking. Even when you join a suitable trial, the outcomes are far from a sure thing.

Such has been the case for Barlow.

After she found out the lung cancer had spread to her lymph nodes and liver, she started an 18-week course of intravenous chemotherapy -- carboplatin, pemetrexed (Alimta) and bevacizumab (Avastin). Then there was some good news: The treatment had stabilized or shrunk all of the tumors.

A year later, her doctor found that the liver tumors were back. Because he discovered Barlow carried the ALK gene mutation, he suggested she join a clinical trial for a medication called crizotinib (Xalkori).

Initially, she didn't know if she was taking the real drug or a placebo. "That was a concern," she said. "It wasn't great to hear; it was stressful." Later in the trial, all patients were able to get the actual drug and placebos were no longer given to anyone, she said.

Barlow took Xalkori for two years, but last year the cancer returned yet again, requiring three ablations (localized methods to destroy a tumor without removing it) and two chemoembolizations (which deliver chemotherapy directly to the liver tumor while minimizing exposure to healthy tissues). Those procedures were not effective, and the next step was surgery to remove almost half of her liver.

Then, when tumor growth appeared in the new liver tissue that had grown back after the surgery, her doctors suggested she try a second clinical trial for a drug called LDK 378, which is being developed by Novartis.

The treatment continues to be tough. "This drug is a lot more difficult for me to take [than the drugs in the first clinical trial]," she said. "There are a lot of side effects, like nausea and vomiting."

Although the medication seems to be shrinking her liver tumors, just recently she had problems with a lung infection and a collapsed lung after a bronchoscopy. That has forced her to take a break from the trial; she hopes to restart as soon as the infection is gone.

Barlow continues to work, traveling with the team when she can. When she's sidelined by her illness, she's frustrated. "I can't believe I had to miss opening day [for the Orioles] this year," she said.

Because she has what she calls "excellent insurance," Barlow hasn't had to face serious medical bills. There is no charge for the care associated with her clinical trial, she said. But she and her family pay for the cost of traveling to her clinical trial site in Philadelphia, including hotel and meals, which can add up when she has an occasional hospital stay there, she added.

The drug Barlow is taking now wasn't available when she was diagnosed three years ago, she said.

"There are so many new things coming out, changing how cancer is being treated, so it's really important to be your own advocate or have someone who is advocating for you," she said. "The Internet can be a huge way to help you stay on top of the latest resources."

Barlow's fight highlights the potential value of a new system to help people more easily access clinical trials, both near and far from home.

A new Internet resource, MyClinicalTrialLocator.com, has just been launched to make it easier for people to find clinical trials that fit their needs.

Dr. Bruce Moskowitz, an internist in West Palm Beach, Fla., gave $100,000 from the Bruce and Marsha Moskowitz Foundation to help support the development of the free website.

"We made this site to be easy to use and understandable to anybody: patient-centric, not doctor-centric," Moskowitz said. "Hopefully, anyone will be able to receive help if they need it."

The website is designed to help visitors search for trials available by medical condition, treatment, location, medical center or other terms. It's accurate, updated frequently and includes information from clinicaltrials.gov (sponsored by the U.S. National Institutes of Health) and academic medical centers, Moskowitz said.

The site offers information about clinical trials worldwide, provides a mapping function to pinpoint the location of a trial and will notify users when trials matching their needs become available. It also allows patients to email clinical trial researchers directly, and academic medical centers can update and correct information on the site in real time.

Despite her many challenges, Barlow thinks clinical trials will help extend her life. "I know this drug won't work forever. But there will be other drugs out there, drugs [that are now] in the early stage of development, and when I need them, I'll switch to those drugs," she said. "The answers are out there; it's just a matter of researchers finding them."

MedicalNews
Copyright © 2013 HealthDay. All rights reserved. SOURCES: Monica Barlow, Ellicott City, Md.; Bruce Moskowitz, M.D., internist, West Palm Beach, Fla.; March 27, 2013, press release, Biomedical Research and Education Foundation and the Bruce and Marsha Moskowitz Foundation



View the original article here

Too Much Texting, Facebook Time May Lower College Women's Grades

News Picture: Too Much Texting, Facebook Time May Lower College Women's GradesBy Alan Mozes
HealthDay Reporter

FRIDAY, April 19 (HealthDay News) -- Media use is a serious distraction for college freshmen, with a new study finding young women devote up to 12 hours daily on pursuits such as texting, posting status updates and surfing the web.

And the more time spent using media, the research suggests, the worse their academic performance.

"The implication of these results would seem to be that reducing college students' media use might improve their academic performance," said study lead author Jennifer Walsh, an assistant professor at the Miriam Hospital Centers for Behavioral and Preventive Medicine in Providence, R.I.

"However, given the central role media play in the lives of young people, this may not be a practical goal for educators and parents," Walsh added. Instead, she said, professors might try to integrate social media into their classrooms to remind students of assignments, suggest resources and connect them with classmates.

For the study, which was published in the April 11 online issue of the journal Emerging Adulthood, researchers surveyed nearly 500 female freshmen at a university in the northeastern United States.

They were asked to recall how they spent their prior week in terms of 11 activities: watching television or movies; listening to music; surfing the Internet; social networking; texting; talking on the phone; reading magazines, newspapers or non-school-related books; and playing video games.

GPA results were collected in January and June. The women were also asked to grade their academic confidence and to note potential problems such as lack of sleep, use of drugs or alcohol, and failure to attend class or complete homework.

When the likelihood of multi-tasking was taken into account (using media while engaging in other non-media-related activities), the authors found the students were devoting nearly 12 hours a day on average to media-based activities.

And those with more media usage were more likely to report behaviors likely to hurt their academic performance. The exceptions: listening to music and reading newspapers were linked to higher grades.

Walsh said it's not possible to draw a direct cause-and-effect relationship between excessive technology use and poor academic performance. More research is needed to do that, she said.

One communications expert challenged the findings, calling them misleading.

"It is absolutely not the case that college women spend nearly half their day using media," said Jeffrey Hall, an associate professor in the department of communication studies at the University of Kansas, in Lawrence. Previous research has found that almost 30 percent of media time involves multi-tasking -- such as listening to music while texting, he said. If that figure were applied to this research, women would have spent closer to nine hours daily on media use. Hall called this "a more reasonable estimate."

Walsh said it's unknown whether the findings apply to male freshmen, given that this research focused solely on women.

"However, young women and men tend to spend approximately the same amount of time using media, and thus we might expect media to interfere with men's academic success in similar ways," she said.

Hall agreed. "There is no reason to believe that these results wouldn't apply to males, but there is also not research in this particular article to say that they would," he said. "We just don't know."

The research team's theories as to how cell phone use and social networking might be linked to worse academic performance do have merit, Hall added.

"Consider the fact that making priorities is very hard for students," he said. "And social networking is extremely compelling. Students feel that Facebook friends' comments on your status update can't wait, but class preparation can."

The other explanation, Hall said, "is that students who don't have the personalities that naturally lead them to be prepared for class are most vulnerable to the temptations of [social networking]. I think both are quite likely."

There is stronger evidence that cell phone use is directly and negatively associated with spring GPA than is social networking, Hall said.

"In some of my own research, students who talk on their cell phones more to close friends report feeling entrapped by the always-on nature of their mobile device," Hall said.

"They get the good part -- feeling close to and well connected to friends, a priority for young women especially," he said. "But [they get] the bad part too -- feeling trapped and guilty and unable to switch off."

MedicalNews
Copyright © 2013 HealthDay. All rights reserved. SOURCES: Jennifer Walsh, Ph.D. assistant professor, Miriam Hospital Centers for Behavioral and Preventive Medicine, Providence, R.I.; Jeffrey Hall, Ph.D., associate professor, communication studies, University of Kansas, Lawrence; April 11, 2013 Emerging Adulthood, online



View the original article here

Am I lightly active or moderatly active?

If I exercise on the elliptical for 30 min. at 3 mph 5 days a week plus 30 min. of low intensity yoga 5 days a week am I considered lightly active or moderately active?

View the original article here

Hailee Steinfeld at CinemaCon

Sorry, I could not read the content fromt this page.

View the original article here

Infection, autoimmune disease linked to depression

Patrick J. Skerrett
Posted June 17, 2013, 5:47 am Bacteria in the bloodstream

Depression, bipolar disorder, and other mental health problems arise when something goes wrong with brain function. What causes that malfunction is an open question. In some people, a serious infection or autoimmune disease could be the trigger.

A report published online in JAMA Psychiatry explores this hypothesis. Researchers turned to comprehensive Danish databases that include all Danes born in the country, each identified by a unique registration number. One of the databases stores health-related information, including records of hospitalizations. Among Danes born between 1945 and 1995, almost 92,000 had a mood disorder. Of these, 36,000 had suffered a severe infection or developed an autoimmune disease (such as type 1 diabetes, celiac disease, lupus, and the like) at some point before being diagnosed with the mood disorder.

People who had been treated for a severe infection were 62% more likely to have developed a mood disorder than those who never had one. An autoimmune disease increased the risk by 45%. Multiple infections or the combination of severe infection and an autoimmune disease boosted the odds of developing depression, bipolar disorder, or another mood disorder even further.

The researchers estimated that in the Danish population, severe infection and autoimmune disease account for 12% of mood disorders.

“A link between infection and depression and mood disorders is intriguing,” says Dr. Michael C. Miller, assistant professor of psychiatry at Harvard Medical School and a member of JAMA Psychiatry’s editorial board. “But it’s important to keep in mind that both infections and mood disorders are very common, making it difficult to tease out what causes what.”

He ticks off three possible explanations for the results:

Severe infection and autoimmune disease may cause mood disorders.Mood disorders may create a susceptibility to infection or autoimmune disease.Mood disorders, severe infection, and autoimmune disorders may share common triggers.

The Danish study isn’t the first to explore links between infection or autoimmune diseases and depression. Much of the evidence supports a connection.

Depression isn’t the only mental health issue that may be related to infections and autoimmune condition. Writing last year in the Harvard Health blog, Dr. Jeff Szymanski described how some children with strep throat suddenly develop obsessive-compulsive disorder. It’s one manifestation of pediatric acute-onset neuropsychiatric syndrome. Quick treatment with antibiotics can reverse the problem.

How might an infection or autoimmune disorder lead to a mood or other mental health disorder? Infection causes localized and body-wide inflammation. Inflammation generates substances called cytokines that have been shown to change how brain cells communicate. In autoimmune diseases, the body’s defense system attacks healthy tissues rather than threatening invaders. It’s possible that in some cases the wayward immune reaction could target brain cells and other nerve cells throughout the body.

The connection between infection, autoimmune disease, inflammation, and mood disorders has prompted some researchers to wonder “Can we vaccinate against depression?” The short answer, at least for now, is “no.”

But there are things you can do. “Healthy living has all sorts of benefits,” says Dr. Miller. It can help you fight infection, reduce inflammation, ease stress, and make you feel better day to day, all of which work against the development of a mood disorder.”

Share

View the original article here

Get a sneak peek at 2013s May Giveaway

GLAMOUR's famous May Beauty Giveaway has returned and this year it's better than ever.

We have 21,255 beauty products to giveaway every day from brands like Benefit, Dr Hauschka, Elemis and L'Oreal.

There's 100s (and even 1000s) of moisturisers, mascaras, perfumes and hair products up for grabs throughout the month. One day, we're even giving 30 lucky winners a £100 shopping voucher (how generous are we?).

You can enter the competition at GLAMOUR.COM from midnight on 1 May but you need to get a head-start, so checkout the May issue of GLAMOUR (pg 260) to see what you can win every day and plan your month around it.

The May issue of GLAMOUR is on sale in all newsagents. Get 6 issues for £6 when you sign up to subscribe

« Back to more Beauty News

View the original article here

Anyone 300lb plus?

I'm am! And I'd love it if i could find people like me so we could beat it together! Would like to be around 200lb for next June when hoping to get married!

Any takers??


View the original article here

Health Tip: Make Kids Safe in the Sandbox

(HealthDay News) -- Kids love to have fun in the sand, but parents should take steps to make sure that sandboxes aren't dirty or contaminated and potentially harmful to kids.

The American Academy of Pediatrics offers this advice for keeping sandboxes safe:

Always keep the sandbox covered when not in use to repel insects and animals.If the sand is wet, allow it to thoroughly dry before covering to prevent the growth of bacteria.Frequently rake the sandbox to get rid of debris.Don't let pets play in the sandbox. They may confuse it with a litter box.

-- Diana Kohnle MedicalNews
Copyright © 2013 HealthDay. All rights reserved.



View the original article here

morbidly obese and everyone says im loosing too fast

Morbidly obese and everyone says I'm loosing to fast. I eat 1000 to 1100 calories a day and loose 5 pounds a week....I am eating tons of food...more than I ever have...but all really low calorie and heathy. I biked 15 miles and walked 2 miles today. I work out twice a day. People r freaking out on me that I'm killing myself. I don't understand. Isn't being morbidly obese killing myself. I am 5 ft 2 in and was 295...10 weeks and I'm 258. I feel proud. Why why why why can't this be okay?

View the original article here

As Pedestrian's Age Rises, So Does Odds of Dying in Traffic Accident

News Picture: As Pedestrian's Age Rises, So Does Odds of Dying in Traffic Accident

THURSDAY, April 18 (HealthDay News) -- Elderly pedestrians face a much higher risk of being killed in a traffic accident than the young do, a new government report finds.

The analysis of 2001-2010 U.S. data showed that traffic-related death rates for men and women aged 75 and older were more than double those of people aged 34 and younger.

Overall, pedestrians make up 4,000 of the nearly 34,000 traffic-related deaths occurring in the United States each year, according to researchers from the U.S. Centers for Disease Control and Prevention.

The number of elderly killed while walking on America's road could even increase given the aging of the U.S. population, said CDC experts commenting on the finding.

They noted that older adults actually take fewer walks than younger people, "however, when struck, older adult pedestrians are more likely to die from their injuries."

Increasing frailty may leave the elderly more vulnerable to being hit by traffic, as well. Age-linked declines in mental function, vision and physical disabilities "might place older adult pedestrians at greater risk for being struck by a vehicle," the CDC added.

Between 2001 and 2010, more than 47,000 Americans died in traffic-related pedestrian deaths, with males having more than double the risk of being hit and killed versus females. It's been suggested that this may be because males tend to walk in more dangerous settings or take more chances when walking.

About three-fourths of pedestrian deaths occurred in cities, the researchers said.

The study appears in the April 19 issue of the CDC publication Morbidity and Mortality Weekly Report.

When the researchers looked at ethnic/racial groups, they found that American Indians/Alaskan Natives had the highest death rates, while whites had the lowest death rates.

Pedestrian fatalities can be prevented, the CDC said, and efforts to do so should include installing speed bumps on certain roadways, enforcing speeding and distracted driving laws, and "creating pedestrian safety zones and streets designated for walking."

-- Robert Preidt MedicalNews
Copyright © 2013 HealthDay. All rights reserved. SOURCE: U.S. Centers for Disease Control and Prevention, news release, April 18, 2013



View the original article here

Treatment for New, Deadly Coronavirus Shows Promise

News Picture: Treatment for New, Deadly Coronavirus Shows Promise

THURSDAY, April 18 (HealthDay News) -- A treatment for a new coronavirus that has caused 11 deaths, mostly in the Middle East, shows promise in early tests, U.S. government researchers report.

The investigators discovered that a combination of two antiviral drugs -- ribavirin and interferon-alpha 2b -- can stop the so-called nCoV coronavirus from multiplying in laboratory-grown cells. While the results suggest that this drug combination could be used to treat patients infected with nCoV, more research is needed to confirm these early findings.

Both drugs are approved in the United States for treating people with hepatitis C.

The nCoV coronavirus was first identified in Saudi Arabia in September 2012. As of April 16, 2013, there had been 17 reported cases, including 11 deaths. Most cases have occurred in the Middle East.

While the number of cases is small, there has been person-to-person transmission of the nCoV coronavirus in situations where people -- mainly family members -- have had close contact with infected people, the researchers noted in a news release from the U.S. National Institute of Allergy and Infectious Diseases (NIAID).

That, along with the high death rate, led the NIAID researchers to look for treatments. In laboratory tests using cells from two monkey species, the research team found that either ribavirin or interferon-alpha 2b alone could stop nCoV from replicating in the cells.

However, the drug concentrations needed to do this were higher than what is recommended for people. The researchers then combined the two drugs, and found that they were effective at a dose that can be used in people, according to the study in the April 18 issue of the journal Scientific Reports.

-- Robert Preidt MedicalNews
Copyright © 2013 HealthDay. All rights reserved. SOURCE: U.S. National Institute of Allergy and Infectious Diseases, news release, April 18, 2013



View the original article here

how to keep motivated when you have no support

I lost 35 lbs last September and my husband lost the 50 he wanted and now that he's done I get no support goes up town brings back candy, cooks high calorie and fat meals and when I say something he says why should he have to suffer need help - Christy

View the original article here

Anthony Kiedis kisses girlfriend in Los Angeles

Shortly after this, the Red Hot Chili Peppers' frontman got on a Harley Davidson and rode into the blistering Californian sunset. Not jealous. Not jealous of your boyfriend at all, random lady.

MUSIC: THIS WEEK WE'RE LOVING...


View the original article here